Histopathology of Post-Transplant Liver Biopsies, the First Report From Iran

Authors Information
Article Notes and Dates
To Cite : Geramizadeh B, Motevalli D, Nikeghbalian S, Malek Hosseini S A. Histopathology of Post-Transplant Liver Biopsies, the First Report From Iran, Hepat Mon. 2013 ;13(6):e9389. doi: 10.5812/hepatmon.9389.
Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Yu YY, Ji J, Zhou GW, Shen BY, Chen H, Yan JQ, et al. Liver biopsy in evaluation of complications following liver transplantation. World J Gastroenterol. 2004; 10(11): 1678-81[PubMed]
  • 2. Adeyi O, Fischer SE, Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation. J Clin Pathol. 2010; 63(1): 47-74[DOI][PubMed]
  • 3. Gao ZH. Seeking beyond rejection: an update on the differential diagnosis and a practical approach to liver allograft biopsy interpretation. Adv Anat Pathol. 2009; 16(2): 97-117[DOI][PubMed]
  • 4. Portmann B. Liver allograft pathology and biopsy interpretation. Verh Dtsch Ges Pathol. 2004; 88: 29-38[PubMed]
  • 5. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997; 25(3): 658-63[DOI][PubMed]
  • 6. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000; 31(3): 792-9[DOI][PubMed]
  • 7. Drebber U, Torbenson M, Wedemeyer I, Dienes HP. [Current aspects of liver allograft pathology]. Pathologe. 2011; 32(2): 113-23[DOI][PubMed]
  • 8. Neil DA, Hubscher SG. Current views on rejection pathology in liver transplantation. Transpl Int. 2010; 23(10): 971-83[DOI][PubMed]
  • 9. Cong WM, Zhang SY, Wang ZL, Xue L, Liu YS, Zhang SH. [Pathologic diagnosis of 1123 post-transplant liver biopsies from 665 liver transplant patients]. Zhonghua Bing Li Xue Za Zhi. 2005; 34(11): 716-9[PubMed]
  • 10. Gornicka B, Ziarkiewicz-Wroblewska B, Bogdanska M, Oldakowska-Jedynak U, Wroblewski T, Morton M, et al. Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience. Transplant Proc. 2006; 38(1): 221-5[DOI][PubMed]
  • 11. Calvaruso V, Dhillon AP, Tsochatzis E, Manousou P, Grillo F, Germani G, et al. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation. J Gastroenterol Hepatol. 2012; 27(7): 1227-32[DOI][PubMed]
  • 12. Guido M, Fagiuoli S, Tessari G, Burra P, Leandro G, Boccagni P, et al. Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut. 2002; 50(5): 697-700[PubMed]
  • 13. Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009; 9(4): 746-57[DOI][PubMed]
  • 14. Proposito D, Loinaz Segurola C, Garcia Garcia I, Jimenez C, Gonzalez Pinto I, Gomez Sanz R, et al. [Assessment of risk factors in the incidence of hepatic artery thrombosis in a consecutive series of 687 liver transplantations]. Ann Ital Chir. 2001; 72(2): 187-205[PubMed]
  • 15. Yilmaz N, Shiffman ML, Todd Stravitz R, Sterling RK, Luketic VA, Sanyal AJ, et al. Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years. Liver Int. 2008; 28(1): 72-8[DOI][PubMed]
  • 16. Seehofer D, Rayes N, Neumann UP, Meisel H, Oettle H, Nussler NC, et al. Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis. Transpl Int. 2005; 18(8): 941-8[DOI][PubMed]
  • 17. Geramizadeh B, Nikeghbalian S, Janghorban P, Malekhosseini SA. Isolated Tuberculosis of Transplanted Liver, A Case Report and Review of the Literature. Hepat Mon. 2013; 13(5)
  • 18. Izadi M, Taheri S. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey. Ann Transplant. 2011; 16(1): 39-47[PubMed]
  • 19. Geramizadeh B, S. N, Dehghani SM, Bahador A, Salahi H, Malek-Hosseini SA. Primary Involvement of allografted liver in Post-Transplant Lymphoproliferative Disorders, Report of Two Pediatric cases and Review of the Literature. IRCMJ. 2012; 14(11): 724-6
  • 20. Mohi-ud-din R, Lewis JH. Drug- and chemical-induced cholestasis. Clin Liver Dis. 2004; 8(1): 95-132, vii[DOI][PubMed]
  • 21. Studniarz M, Czubkowski P, Cielecka-Kuszyk J, Jankowska I, Teisseyre M, Kaminska D, et al. Amoxicillin/clavulanic acid-induced cholestatic liver injury after pediatric liver transplantation. Ann Transplant. 2012; 17(1): 128-31[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check